24 August 2023: Clinical Research
Assessing the Impact of Hepatitis B Elimination Program on Maternal-Infant Health in West Java, Indonesia: A Cross-Sectional Study
Anita Deborah Anwar 1ABCDEFG , Annisa Dewi Nugrahani 1ABCDEF* , Dhanny Primantara Johari Santoso 1ABCDE , Muhammad Alamsyah Aziz 1ADEF , Lia Ulfah 2BCD , Asep Surachman 3BDOI: 10.12659/MSM.941639
Med Sci Monit 2023; 29:e941639
Table 4 Subgroup analysis of infant characteristics.
| Variables | Total (n=62) | Infant HBsAg status | P value | |
|---|---|---|---|---|
| HBsAg (+) | HBsAg (−) | |||
| 0.144 | ||||
| Yes | 39 | 1 | 38 | |
| No | 20 | 1 | 19 | |
| 0.029* | ||||
| Yes | 44 | 1 | 43 | |
| No | 24 | 1 | 14 | |
| 1.000 | ||||
| Yes | 56 | 2 | 54 | |
| No | 3 | 0 | 3 | |
| * For numerical data, the value was tested with the unpaired t-test if the data were normally distributed, and with an alternative Mann-Whitney test if the data were not normally distributed. For categorical data, the value was calculated based on the chi-square test with an alternative Exact Fisher’s exact test if the conditions of the chi-square test were not met. For the delivery method group, analysis was conducted using the Kolmogorov-Smirnov test. Statistical significance was set at value HBIG – hepatitis B immune globulin; HBV vaccine – hepatitis B vaccine; HBsAg – hepatitis B surface antigen. | ||||